Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis.
National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, United Kingdom.
Shameem
S
Mahmood
Julie
J
Blundell
Anja
A
Drebes
Philip N
PN
Hawkins
Ashutosh D
AD
Wechalekar
D000686:Amyloidosis / Q000150:complications* / Q000378:metabolism*; D005170:Factor X / Q000008:administration & dosage / Q000627:therapeutic use*; D005171:Factor X Deficiency / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000378:metabolism*; D016896:Treatment Outcome
D007147:Immunoglobulin Light Chains; D005170:Factor X